KalshiFechadoVerificar disponibilidadeKYC obrigatório2% de taxaDados de resolução verificadosRazoavelmente calibradoEste mercado está fechado e aguardando uma resolução confirmada.
Aguardando resolução verificada
A CoinRithm aguarda uma liquidação confirmada pelo provedor antes de tratar este mercado como resolvido.
Probabilidade implícita atual
Before 2027 35%Líder entre 3 opções
Qualidade do mercado
35 / 100
Baixa qualidadeVolume 24h
—
Liquidez
29,7 mil €
Alta liquidezDados do mercado
Atualizado há 12 minutos
24/03/26, 14:00 UTC1/09/26, 03:59 UTC
Tendências
35%
20%
2%
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
FDA moves BPC-157 to Category 1 by which date?
PolymarketHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWill we get AGI before 2027?
Manifold MarketsFDA approves skin cancer vaccine by which date?
PolymarketMeasles cases in 2026?
KalshiRegras
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.
Liquida via:Food and Drug Administration
- The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility.
- Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
Mercados abertos
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No97%
- Yes3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 18 mil
POLYMARKETNew pandemic in 2026?
- No94.1%
- Yes5.9%
- Volume total
- € 920,1 mil
- Volume 24h
- € 4 mil
KALSHIMedtronic cardiovascular growth in Q2
- Above 8%92%
- Above 9%81%
- Above 11.5%53%
+6 mais resultados
- Volume total
- € 2,6 mil
- Volume 24h
- € 2,6 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt98%
- Above 6000+2.0pt61%
+2 mais resultados
- Volume total
- € 868,1 mil
POLYMARKETMeasles cases in U.S. in 2026?
- ↑3.5k100%
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
+9 mais resultados
- Volume total
KALSHIPandemic in 2026?
- No95%
- Yes5%
- Volume total
- € 612,7 mil
- Volume 24h
- € 1,2 mil
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Which countries will report an Ebola disease case before October?
- What will RFK say during RNC Midterm Convention?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will the FDA approve retatrutide?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- Measles cases in U.S. by September 30?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
Perguntas frequentes
- Quais são as probabilidades atuais de When will the FDA reclassify BPC-157 to Category 1??
- A Kalshi cota Before 2027 em 35% em 10 de setembro de 2026.
- Quando When will the FDA reclassify BPC-157 to Category 1? é resolvido?
- When will the FDA reclassify BPC-157 to Category 1? deverá ser resolvido em 1 de setembro de 2026.
- Como When will the FDA reclassify BPC-157 to Category 1? é liquidado?
- A Kalshi liquida este mercado da seguinte forma: If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.